Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-736
Closed -$216K 240
2020
Q4
$216K Sell
736
-235
-24% -$60.3K 0.02% 286
2020
Q3
$230K Sell
971
-1,525
-61% -$347K 0.03% 237
2020
Q2
$496K Buy
2,496
+7
+0.3% +$1.31K 0.06% 161
2020
Q1
$457K Hold
2,489
0.06% 155
2019
Q4
$415K Hold
2,489
0.06% 186
2019
Q3
$326K Hold
2,489
0.06% 221
2019
Q2
$302K Sell
2,489
-176
-7% -$20.9K 0.06% 251
2019
Q1
$328K Hold
2,665
0.07% 209
2018
Q4
$312K Buy
+2,665
New +$314K 0.08% 172

Other funds holding AMED

Magnus Financial Group's AMED Position: Q1 2021 in Review

Magnus Financial Group sold out of Amedisys (AMED) in Q1 2021, closing a stake of 736 shares — an estimated $216K sold.

Magnus Financial Group first reported a position in AMED in Q4 2018 and held it in 9 quarters. The position peaked at $496K in Q2 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Magnus Financial Group reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Magnus Financial Group sold 736 Amedisys shares in Q1 2021, an estimated $216K.
  • Magnus Financial Group first reported a position in Amedisys in Q4 2018 and held it in 9 quarters.
  • Magnus Financial Group's Amedisys position peaked at $496K in Q2 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Magnus Financial Group's 13F filing for Q1 2021, filed 5 May 2021.